Abstract

Microglial FDG uptake alterations are the source of FDG-PET changes in models of neurodegenerative diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cell sorting after tracer injection to elucidate allocation of cellular FDG uptake in different cell types and different microglial activation states
Matthias Brendel
Alzheimer's & Dementia: The Journal of the Alzheimer's Association | VOL. 18
Matthias BrendelMatthias Brendel
01 Dec 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspective.
Peter Bloomingdale ... Tatiana Karelina
CPT: Pharmacometrics & Systems Pharmacology | VOL. 11
Peter Bloomingdale, et. al.Peter Bloomingdale ... Tatiana Karelina
17 Aug 2022
NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
Hui-Ming Gao ... Jau-Shyong Hong
Trends in Pharmacological Sciences | VOL. 33
Hui-Ming Gao, et. al.Hui-Ming Gao ... Jau-Shyong Hong
11 Apr 2012
Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs.
Moustafat Gabr ... Somayaa Abdelrahman
Neural regeneration research | VOL. 17
Moustafat Gabr, et. al.Moustafat Gabr ... Somayaa Abdelrahman
08 Jul 2021
View more papers

More From: Science translational medicine

Paper Title
Journal
Date
Author
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models.
Nikole L Warner ... Jesse H Erasmus
Science Translational Medicine | VOL. 16
Nikole L Warner, et. al.Nikole L Warner ... Jesse H Erasmus
07 Aug 2024
Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice.
Marisa Zallocchi ... Jian Zuo
Science Translational Medicine | VOL. 16
Marisa Zallocchi, et. al.Marisa Zallocchi ... Jian Zuo
07 Aug 2024
In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis.
Prashanth Thevkar Nagesh ... Gyongyi Szabo
Science Translational Medicine | VOL. 16
Prashanth Thevkar Nagesh, et. al.Prashanth Thevkar Nagesh ... Gyongyi Szabo
07 Aug 2024
Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer's disease.
Jihoon Han ... Dong-Gyu Jo
Science Translational Medicine | VOL. 16
Jihoon Han, et. al.Jihoon Han ... Dong-Gyu Jo
07 Aug 2024
View more papers